Effect of Interval Between Neoadjuvant Chemotherapy and Surgery on Oncological Outcomes in Poor Responders With Locally Advanced Breast Cancer-Reference-Cited by-同舟云学术

Effect of Interval Between Neoadjuvant Chemotherapy and Surgery on Oncological Outcomes in Poor Responders With Locally Advanced Breast Cancer

Published:2024 Issue:4 Volume:27 Page:270
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Long Man¹^ORCID,Li Chunxia²^ORCID,Mao Keyu¹^ORCID,Li Zhenhui¹^ORCID,Li Zhen³^ORCID,Dong Guili¹^ORCID,Zheng Xia¹^ORCID,Gao Songliang¹^ORCID,Li Zhuolin¹^ORCID,Yang Guangjun¹^ORCID,Xie Yu¹^ORCID

Affiliation:

1. Department of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.

2. Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.

3. Third Department of Breast Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.

Funder

Yunnan Fundamental Research Projects

Major Science and Technology Projects in Yunnan Province

Publisher

XMLink

Link

https://ejbc.kr/pdf/10.4048/jbc.2024.0084

Reference16 articles.

1. Locoregional therapy in breast cancer patients treated with neoadjuvant chemotherapy

2. Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

3. Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

4. The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)

5. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy